Atlas Trials

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Clinical trial NCT03898479 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03898479
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2019-04-04
Primary completion
2027-05-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.